{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-26-000061","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2026-08-06T20:13:52+00:00","discovered_at":"2026-08-06T20:15:12.563301+00:00","generated_at":"2026-08-06T20:18:29.808785+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"INNOVATE Q2 net income $10.4M vs loss; revenue up 74% to $421.6M; DBMG record quarter","bullets":["Revenue $421.6M (+74.2% YoY); diluted EPS $0.71 vs ($1.67); Total Adj. EBITDA $46.3M (+194.9%).","Infrastructure (DBMG) revenue $414.0M (+77.6%), net income $26.4M, Adj. EBITDA $48.7M; adjusted backlog $2.7B.","Broadcasting refinanced with $105M loan; INNOVATE agreed to sell ~75% stake to CONX, retaining ~25%.","Life Sciences: MediBeacon engaged with 100+ institutions; R2 revenue $2.2M, opex cut 50% YoY.","Pursuing asset dispositions including sale of DBMG assets/equity and majority of Broadcasting."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-26-000061","json":"https://secwatch.observer/filing/0001006837-26-000061.json","markdown":"https://secwatch.observer/filing/0001006837-26-000061.md","text":"https://secwatch.observer/filing/0001006837-26-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683726000061/0001006837-26-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683726000061/vate-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:18:29.808785+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}